SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

BRIEF-Novavax Announces Positive Preclinical Data For Combination Influenza And Covid-19 Vaccine Candidate

05/10/2021 09:39
BRIEF-Novavax Announces Positive Preclinical Data For Combination Influenza And Covid-19 Vaccine Candidate

- Novavax Inc NVAX.O:

  • NOVAVAX ANNOUNCES POSITIVE PRECLINICAL DATA FOR COMBINATION INFLUENZA AND COVID-19 VACCINE CANDIDATE

  • NOVAVAX INC - NANOFLU/NVX-COV2373 COMBINATION VACCINE DEMONSTRATED POSITIVE IMMUNE RESPONSES TO BOTH INFLUENZA AND SARS-COV-2

  • NOVAVAX INC - CLINICAL STUDIES OF COMBINATION VACCINE ARE EXPECTED TO BEGIN BY END OF YEAR

Source text for Eikon: ID:nCNW8DKXra

Further company coverage: NVAX.O


(([email protected];))